CFM
GILD icon

Catalyst Funds Management’s Gilead Sciences GILD Stock Holding History

Catalyst Funds Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$935K Buy
7,400
+3,609
+95% +$476K 0.05% 302
2026
Q1 		$528K Buy
+3,791
New +$531K 0.09% 238
2025
Q4 		– Sell
-6,400
Closed -$710K – 427
2025
Q3 		$710K Buy
+6,400
New +$727K 0.11% 185
2025
Q2 		– Sell
-10,440
Closed -$1.17M – 542
2025
Q1 		$1.17M Buy
+10,440
New +$1.08M 0.31% 97
2024
Q4 		– Sell
-3,000
Closed -$252K – 716
2024
Q3 		$252K Buy
3,000
+2,600
+650% +$198K 0.06% 230
2024
Q2 		$27.4K Sell
400
-28,700
-99% -$1.92M 0.01% 581
2024
Q1 		$2.13M Buy
+29,100
New +$2.24M 0.6% 47

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Catalyst Funds Management's GILD Position: Q2 2026 in Review

Catalyst Funds Management increased its Gilead Sciences (GILD) stake by 95% in Q2 2026, buying an estimated $476K and bringing the position to 7,400 shares worth $935K. The position accounts for 0.05% of the portfolio, ranked #302.

Catalyst Funds Management first reported a position in GILD in Q1 2024 and has held it in 7 quarters since. The position peaked at $2.13M in Q1 2024. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Catalyst Funds Management held 7,400 shares of Gilead Sciences worth $935K as of Q2 2026.
  • Catalyst Funds Management bought 3,609 Gilead Sciences shares in Q2 2026, an estimated $476K.
  • Gilead Sciences made up 0.05% of Catalyst Funds Management's portfolio in Q2 2026, its #302 holding.
  • Catalyst Funds Management first reported a position in Gilead Sciences in Q1 2024 and has held it in 7 quarters since.
  • Catalyst Funds Management's Gilead Sciences position peaked at $2.13M in Q1 2024.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.